A012103 OptimICE-PCR: De-escalation of Therapy in Early -stage TNBC Patient who achieve PCR After Neoadjuvant Chemotherapy with Check point inhibitor Therapy

  • Trial Category: Breast

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Methodist Estabrook Cancer Center, Omaha, NE

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*